DE60040555D1 - Küle - Google Patents

Küle

Info

Publication number
DE60040555D1
DE60040555D1 DE60040555T DE60040555T DE60040555D1 DE 60040555 D1 DE60040555 D1 DE 60040555D1 DE 60040555 T DE60040555 T DE 60040555T DE 60040555 T DE60040555 T DE 60040555T DE 60040555 D1 DE60040555 D1 DE 60040555D1
Authority
DE
Germany
Prior art keywords
scfv
dam
cules
disease
applicatrions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60040555T
Other languages
English (en)
Inventor
Alan Kingsman
Susan Mary Kingsman
Christopher Robert Bebbington
Miles William Carroll
Fiona Margaret Ellard
Kevin Alan Myers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Biomedica UK Ltd
Original Assignee
Oxford Biomedica UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB1999/003859 external-priority patent/WO2000029428A2/en
Priority claimed from GB0003527A external-priority patent/GB0003527D0/en
Priority claimed from GB0005071A external-priority patent/GB0005071D0/en
Application filed by Oxford Biomedica UK Ltd filed Critical Oxford Biomedica UK Ltd
Priority claimed from PCT/GB2000/004317 external-priority patent/WO2001036486A2/en
Application granted granted Critical
Publication of DE60040555D1 publication Critical patent/DE60040555D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/60Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622Single chain antibody (scFv)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732Antibody-dependent cellular cytotoxicity [ADCC]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2318/00Antibody mimetics or scaffolds
    • C07K2318/10Immunoglobulin or domain(s) thereof as scaffolds for inserted non-Ig peptide sequences, e.g. for vaccination purposes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/30Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Conductive Materials (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60040555T 1999-11-18 2000-11-13 Küle Expired - Lifetime DE60040555D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/GB1999/003859 WO2000029428A2 (en) 1998-11-18 1999-11-18 5t4 tumour-associated antigen for use in tumour immunotherapy
GB0003527A GB0003527D0 (en) 2000-02-15 2000-02-15 Antibodies
GB0005071A GB0005071D0 (en) 2000-03-02 2000-03-02 Antibodies
PCT/GB2000/004317 WO2001036486A2 (en) 1999-11-18 2000-11-13 Scfv antibodies against disease associated molecules

Publications (1)

Publication Number Publication Date
DE60040555D1 true DE60040555D1 (de) 2008-11-27

Family

ID=38233183

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60040555T Expired - Lifetime DE60040555D1 (de) 1999-11-18 2000-11-13 Küle

Country Status (5)

Country Link
US (1) US20070161080A1 (de)
EP (1) EP2161286A1 (de)
KR (1) KR20020049054A (de)
AT (1) ATE411342T1 (de)
DE (1) DE60040555D1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7276488B2 (en) * 1997-06-04 2007-10-02 Oxford Biomedica (Uk) Limited Vector system
NZ500633A (en) * 1997-06-04 2002-10-25 Oxford Biomedica Ltd Vector
JP2003515323A (ja) * 1999-11-18 2003-05-07 オックスフォード バイオメディカ(ユーケイ)リミテッド 抗 体
GB0126378D0 (en) * 2001-11-02 2002-01-02 Oxford Biomedica Ltd Antigen
ES2910365T3 (es) * 2016-04-22 2022-05-12 Alligator Bioscience Ab Nuevos polipéptidos biespecíficos contra CD137
EP3655439A1 (de) 2017-07-20 2020-05-27 Aptevo Research and Development LLC An 5t4 und 4-1bb bindende antigenbindende proteine und zugehörige zusammensetzungen und verfahren

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ500633A (en) * 1997-06-04 2002-10-25 Oxford Biomedica Ltd Vector
EP1036091B2 (de) * 1998-11-18 2008-03-26 Oxford Biomedica (UK) Limited Verwendung vom krebs-assoziierten antigen 5t4 zur immuntherapie
JP2003515323A (ja) * 1999-11-18 2003-05-07 オックスフォード バイオメディカ(ユーケイ)リミテッド 抗 体

Also Published As

Publication number Publication date
KR20020049054A (ko) 2002-06-24
US20070161080A1 (en) 2007-07-12
ATE411342T1 (de) 2008-10-15
EP2161286A1 (de) 2010-03-10

Similar Documents

Publication Publication Date Title
WO2001036486A3 (en) Scfv antibodies against disease associated molecules
DE69007465D1 (de) Integrierter intrakranialer druckmonitor und drainagekatheter.
FR2703254B1 (fr) Dispositif de traitement thérapeutique d'un tissu pathologique, comportant un cathéter .
DE69021153T2 (de) Medizinisches Ventil und Herstellungsverfahren, Katheter und Ventil sowie Kathetereinheit.
DE69535349D1 (de) Implantierbare aktive medizinische Vorrichtung mit Mittel zur Unterscheidung zwischen Ruhe- bzw. Aktivzustand des Patienten
WO2003035142A3 (en) Catheter for modified perfusion
BR0015992A (pt) Compostos, utilização dos mesmos, e, associações terapêuticas
ATE516838T1 (de) Medizinische vorrichtung mit schubkraftbegrenzung
MXPA03000436A (es) Medicamentos que compreden derivados de dicianopiridina.
DE60121988D1 (de) Kombinationstherapie mit antidiabetischen und antikonvulsiven mitteln
BR9609176A (pt) Composi-{es de agente biolÄgico
FR2793678B1 (fr) Manchon elastique a garniture viscoelastique pour la protection ou le soin de doigts ou d'orteils
SE9702860D0 (sv) New use
DK678887A (da) Farmaceutiske praeparater
DE69005340D1 (de) Medizinische Absaug- und Spülvorrichtung.
HU9301253D0 (en) Medical preparative applicable for treatment of enlarged time of coagulation
NO994165D0 (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
KR910019620A (ko) 15-케토-프로스타글란딘 화합물을 사용한 췌장 질병의 치료
DE60040555D1 (de) Küle
KR920002151A (ko) 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
DE60128100D1 (de) Analgetisches arzneimittel
PT1360187E (pt) 3,7-diazabiciclo(3.3.0)octanos e a sua utilizacao no tratamento de arritmias cardiacas
BR0115882A (pt) Emprego de compostos de 1-fenil-3-dimetilaminopropano no tratamento da incontinência urinária
NO20030985D0 (no) Behandling av betennelsestilstander
IT240104Y1 (it) Dispositivo per il trattamento del corpo umano.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition